在儿科耐药性中加拿大二醇的辅助使用:回顾性多中心分析
Ermekbaeva Aizara1, T Varughese Robin2, Li Hanna1
1Tulane University School of Medicine, New Orleans, LA, USA.
Epilepsy & behavior : E&B
|April 27, 2025
概括
大麻 (CBD) 有效地减少了各种原因的耐药性患者的发作频率. 这项研究显示,发作显著减少,为难以管理的综合征提供了有价值的新治疗选择.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
- 发病学 (Epileptology) 是一个专业的学科.
背景情况:
- 影响全球7000万,其中三分之一面临耐药性 (DRE).
- 大麻 (CBD) 对特定的综合征有希望,但对各种病因的数据有限.
- 有限证据表明CBD在更广泛的DRE患者群体中的有效性.
研究的目的:
- 评估大麻素 (CBD) 作为减少DRE患者发作频率的补充疗法的疗效.
- 为了评估CBD在各种病病因谱中的有效性.
- 为了确定CBD对抗性发作的发作减少的影响.
主要方法:
- 在两个中心接受CBD辅助治疗的DRE患者的回顾性图表审查.
- 在基线和至少3个月的随访后记录的发作频率.
- 的诊断被分为五类:焦点/多焦点,初级泛化,伦诺克斯-加斯托综合征,德拉维特综合征以及其他发育和脑病变.
主要成果:
- 49%的患者实现了≥25%的发作减少;5%的患者减少了26-50%.
- 21%的人实现了51-75%的减少,20%的人经历了76-99%的减少,5%的人接近了发作自由.
- 发作频率的中位数显著下降,从30降至8 (p=0.000),所有诊断组都出现了下降.
结论:
- 大麻二醇 (CBD) 是治疗耐药性的有效辅助治疗方法.
- CBD在各种病病因和遗传背景中表现出显著的疗效.
- CBD可以降低发作频率和抗药物的负担,特别是在具有挑战性的综合征中.
更多相关视频
09:57Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
2.6K
05:25Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
Published on: February 28, 2025
180
相关概念视频
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
204
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
204
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
349
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
349
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
273
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
273
01:24CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
167
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
167
01:20Antiepileptic Drugs: Potassium Channel Activators
150
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
150
01:29Drug Delivery: Parenteral Route
445
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
445